These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1719729

  • 21. [Hemodilution, hemorheology and oxygen supply].
    Ehrly AM.
    Acta Med Austriaca; 1991; 18 Suppl 1():3-8. PubMed ID: 1950386
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M, Brechtelsbauer H, Akbulut C, Fett W, Briegel J, Finsterer U.
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [Abstract] [Full Text] [Related]

  • 24. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F, Waldhausen P, Spitzer S, Mrowietz C, Häuser B, Wenzel E.
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [Abstract] [Full Text] [Related]

  • 25. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
    Hensel M, Wrobel R, Volk T, Pahlig H, Kox WJ.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
    [Abstract] [Full Text] [Related]

  • 26. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U, Hütt M, Herrmann B, Seufzer U, Leweling H.
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M, Henkel P, Becker-Scheid D, Schmitt J.
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [Abstract] [Full Text] [Related]

  • 33. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A, Schmidt H, Sternitzky R, Brehme S, Keysser G, Hiebsch G, Hiebsch U.
    Vasa Suppl; 1991 Aug; 32():338-41. PubMed ID: 1771528
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Vagal stimulation - a new possibility for conservative treatment of peripheral arterial occlusion disease].
    Payrits T, Ernst A, Ladits E, Pokorny H, Viragos I, Längle F.
    Zentralbl Chir; 2011 Oct; 136(5):431-5. PubMed ID: 22009541
    [Abstract] [Full Text] [Related]

  • 37. Normovolemic hemodilution in peripheral arterial disease.
    Rieger H, Köhler M, Schoop W, Schmid-Schönbein H.
    Ann Clin Res; 1981 Oct; 13 Suppl 33():78-83. PubMed ID: 7342848
    [Abstract] [Full Text] [Related]

  • 38. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H, Jung F.
    Fortschr Med; 1984 Oct 04; 102(37):921-4. PubMed ID: 6500451
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A, Schmidt HH, Sternitzky R.
    Z Arztl Fortbild (Jena); 1987 Oct 04; 81(17):883-8. PubMed ID: 3439205
    [No Abstract] [Full Text] [Related]

  • 40. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F, Waldhausen P, Mrowietz C, Spitzer S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1989 Aug 04; 16(4):148-54. PubMed ID: 2478482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.